Translational Research Trials (as of August 12, 2020)

ENGOT-ov47-TR /NOGGO-AGO TR2 

Leading group: NOGGO

Clinical Trial Study: Prospective study of HE4 serum level in patients with first platinum sensitive relapsed ovarian cancer.

Planned number of patients: 500

Participating groups:

A-AGO, AGO, BGOG, GEICO, MaNGO, MITO, NCRI

Planned start in May 2018

 

 

Up Coming ENGOT Meeting

ENGOT General Assembly

September 30 - October 1, 2021
Bernstorff Slot
Copenhagen, Denmark

Don't miss out on the latest updates and save the date!

You May Also Like

GCA6

GCA WORKSHOPS

Watch the Webcasts 

 

Read More

background

CLINICAL TRIALS

Latest Published Research

 

Read More

patient2

FOR PATIENTS

Key Insights

 

Read More

540x422

ESGO MEETING

ESGO 2021 Congress

Read More